Drugs / Infanrix+Hib™
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01449812 | Oct 2011 → Jan 2012 | diphtheria, haemophilus infectious disease, tetanus | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Infanrix+Hib | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01449812 ↗ |
| Modality | Vaccine | “Infanrix+Hib™ vaccines” NCT01449812 ↗ |
| Route | Intramuscular | “administered intramuscularly into the upper sides of the left and right thighs” NCT01449812 ↗ |